Gene · 5420
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glucose transporter 1 is essential to maintain brain endothelial cell homeostasis under hyperglycemia condition. | Am J Physiol Cell Physiol | 2025 | 40549566 | PubTator, text mining | PubMed |
| Thin endometrium restricts peri-ovulatory physiological transition between anti-adhesive and adhesive receptivity modulators. | Reprod Biomed Online | 2025 | 40543138 | PubTator, text mining | PubMed |
Stromal Cell-Derived Factor-1, P-Selectin, and Advanced Oxidation Protein Products with Mitochondrial Dysfunction Concurrently Impact Cerebral Vessels in Patients with Normoalbuminuric Diabetic Kidney Disease and Type 2 Diabetes Mellitus. | Int J Mol Sci | 2025 | 40429625 | PubTator, text mining | PubMed |
| Whole genome sequencing identifies monogenic disease in 56.1% of families with early-onset steroid-resistant nephrotic syndrome. | Hum Genet | 2025 | 40402239 | PubTator, text mining | PubMed |
| Renal Implications of Psoriasis: Urinary Podocyte Markers and Disease Progression. | Dermatol Pract Concept | 2025 | 40401891 | PubTator, text mining | PubMed |
| Asperosaponin VI Promotes Osteoporotic Fracture Healing by Targeting Piezo1 to Enhance the Coupling of LEPR+ BMSCs and PODXL+ ECs. | Phytother Res | 2025 | 40393465 | PubTator, text mining | PubMed |
| Single cell transcription revealing key transcription factors in embryonic kidney development. | Mol Cell Biochem | 2025 | 40392427 | PubTator, text mining | PubMed |
| Quantification of Urine and Plasma Levels of Extracellular Vesicles in a Cohort of Kidney Transplant Recipients and Chronic Kidney Disease Patients. | Int J Mol Sci | 2025 | 40332150 | PubTator, text mining | PubMed |
| Preservation of Urinary Podocyte Markers in Diabetic Kidney Disease by Sodium-Glucose Cotransporter 2 Inhibitor Therapy. | Kidney Dis (Basel) | 2025 | 40297470 | PubTator, text mining | PubMed |
| Multi-omic features and clustering phenotypes of circulating tumor cells associated with metastasis and clinical outcomes. | Int Rev Cell Mol Biol | 2025 | 40287221 | PubTator, text mining | PubMed |
| Novel Truncating Variants in PODXL Represent a New Entity to Be Explored Among Podocytopathies. | Genes (Basel) | 2025 | 40282423 | PubTator, text mining | PubMed |
| Correction: The SGK3-triggered ubiquitin-proteasome degradation of podocalyxin (PC) and ezrin in podocytes was associated with the stability of the PC/ezrin complex. | Cell Death Dis | 2025 | 40180941 | PubTator, text mining | PubMed |
| Urinary and Serum Amino Acids May Be Associated with Podocyte, Proximal Tubule, and Renal Endothelial Injury in Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. | Biomedicines | 2025 | 40149650 | PubTator, text mining | PubMed |
| Identification and Validation of Key Biomarkers in the Proximal Aqueous Humor Outflow Pathway. | Curr Issues Mol Biol | 2025 | 40136401 | PubTator, text mining | PubMed |
| Podocyte-Specific Protein Expression in Urine Exosome Acts as a Marker for Renal Injury in Post-COVID State. | Metab Syndr Relat Disord | 2025 | 40100769 | PubTator, text mining | PubMed |
| Identification of lipid metabolism related immune markers in atherosclerosis through machine learning and experimental analysis. | Front Immunol | 2025 | 40070840 | PubTator, text mining | PubMed |
| Development of chimeric antigen receptor T cells targeting cancer-expressing podocalyxin. | Regen Ther | 2025 | 39867135 | PubTator, text mining | PubMed |
| Anti-Adhesive Podocalyxin Expression Is Disrupted in Recurrent Implantation Failure. | Diagnostics (Basel) | 2025 | 39795629 | PubTator, text mining | PubMed |
| Development of a Multiplexed LC-MS/MS Assay for the Quantitation of Podocyte Injury Biomarkers Nephrin, Podocalyxin, and Podocin in Human Urine. | J Proteome Res | 2025 | 39651829 | PubTator, text mining | PubMed |
| Receptive window might be shorter in patients with endometriosis and lesions cyclically prepare for implantation. | F S Sci | 2025 | 39643002 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5420/papers?page=5